Avvinity’s Head of Chemistry presents at the Immuno-Oncology Summit

Mel Glossop, Avvinity’s Head of Chemistry, presented at the Immuno-Oncology Summit, Europe 2020.

Mel presentation, “Immunotherapy by Design – Induction of Systemic Anti-Tumour Immunity by Targeting Recruitment of Natural Antibodies” described the disruptive treatments for cancer using the power of natural antibodies that the company is developing.

More information about this event can be found at this link.